Decreased SIRT1 levels have been found in postmortem tissues from ALS patients [244] and intraperitoneal injection of the SIRT1 activator resveratrol resulted in a significant improvement in both symptoms and survival of SOD1G93A mice [245]. Here, SIRT1 is linked to amyotrophic lateral sclerosis.